Loteprednol etabonate 0.25%
Dry eye · Rx
RxDry eyeDry Eye Rx
| Strength | 0.25% |
|---|---|
| Typical quantity | 8.3 mL bottle |
| Cash cost / month | Specialty · ~$350+ |
| Drug class | Corticosteroid, ester (dry-eye flare) |
| Mechanism of action | Retro-metabolically designed ester corticosteroid; potent local anti-inflammatory that is rapidly de-esterified to an inactive metabolite, lowering IOP-spike and cataract risk. |
| Indication / reason for use | Short-term (up to 2 weeks) treatment of dry-eye disease flares. |
| Usual adult dosing | 1-2 drops in each eye 4×/day for up to 2 weeks. Shake before use. |
| Preservative | BAK 0.01% |
| Contact lenses | Remove lenses before use; do not wear lenses if eyes are inflamed. Reinsert 15 min after dose if wear is permitted. |
| Common / important adverse effects | Instillation-site pain; with longer use, IOP rise, cataract, delayed healing, secondary infection. |
| Contraindications & cautions | Active viral (herpes simplex epithelial keratitis), fungal or mycobacterial ocular infection. |
| Pregnancy / lactation | No adequate data; topical ocular steroid systemic exposure is low. |
| Pregnancy category (older labels) | No letter category on the current label. From DailyMed labels, checked Nov 2026. |
| Trade names | Eysuvis |
| Practice notes | Check IOP if courses are repeated frequently. |
Chair-side reference only. Dosing, contraindications and pregnancy guidance here are not exhaustive. Confirm against the current prescribing information and the patient’s full history before prescribing or advising.